Skip to main content
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: Parkinsonism Relat Disord. 2014 Feb 13;20(5):503–507. doi: 10.1016/j.parkreldis.2014.02.001

Table 3.

Frequency (%) of neuropathologic characteristics in clinical PD

Characteristic APOE e4 carriers (n=10) APOE e4 non-carriers (n=19)
Neuritic plaque frequency
 None 0 (0%) 7 (36%)
 Low 1 (10%) 4 (21%)
 Moderate 4 (40%) 3 (16%)
 Frequent 5 (50%) 5 (26%)
Diffuse plaque frequency
 None 1 (10%) 6 (32%)
 Sparse 1 (10%) 6 (32%)
 Moderate 1 (10%) 3 (16%)
 Frequent 7 (70%) 4 (21%)
Braak stage
 0 0 (0%) 1 (5%)
 I-II 1 (10%) 8 (42%)
 III-IV 7 (70%) 8 (42%)
 V-VI 2 (20%) 2 (11%)
Lewy body pathology
 Not present 0 (0%) 0 (0%)
 Brainstem predominant 2 (20%) 2 (11%)
 Limbic 2 (20%) 6 (32%)
 Diffuse 6 (60%) 9 (48%)
 Unspecified 0 (0%) 2 (11%)